Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]
Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocr…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluated the pharmacokinetics, safety, and tolerability of ZL-2306 (niraparib) in patients with ovarian cancer and…
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
This clinical trial update outlines plans to increase breast and ovarian cancer surveillance in people with hereditary risk and to identify …
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Fermented Wheat Germ Extract in Women With Ovarian Cancer [EARLY_Phase 1]
An early-phase trial evaluating Fermented Wheat Germ Extract in women with ovarian cancer; the study was terminated and results were posted …
-
FDA approval · 2019-01-18FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic cyclophosphamide product. This marks approval of a generic formulation …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-01-18Clinical Trial Update: Imaging Study in Advanced Ovarian Cancer
An imaging study in advanced ovarian cancer sponsored by Charles University is listed. The current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating MRI-guided stereotactic body radiation therapy for ovarian cancer; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer [Phase 1]
This document reports a completed Phase I clinical trial from The Netherlands Cancer Institute evaluating carboplatin-olaparib in combinatio…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018) [Phase 2]
Phase 2 trial update investigating NGR-hTNF in combination with an anthracycline for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]
Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers i…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: CT Antigen TCR-redirected T Cells for Ovarian Cancer. [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating TCR-redirected T cells targeting CT antigen for ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer [Phase 2]
Phase 2 clinical trial of Kevetrin in ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Sentinel Node Detection in Clinical Early Stage Ovarian Cancer [NA]
Completed clinical trial investigating sentinel node detection in early-stage ovarian cancer with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for BIBF 1120 in bevacizumab-resistant, persistent, or recurrent epithelial ovarian cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial update evaluating ixabepilone in relapsed/refractory advanced ovarian epithelial or primary peritoneal cancer has c…
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer [Phase 2]
Phase II study evaluating NGR-hTNF in combination with doxorubicin for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer [Phase 2]
Phase 2 trial evaluating NGR-hTNF in combination with doxorubicin for advanced or metastatic ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer [Phase 3]
Phase 3 trial examining secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy for stage III ovarian cancer h…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Clinical trial update reporting outcomes on health-related quality of life and symptoms for patients recovering from major gynecologic cance…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma [Phase 2]
Phase II study of DCVAC/OvCa with carboplatin and gemcitabine in relapsed platinum-sensitive epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and pemetrexed in recurrent platinum-sensitive ovarian cancer completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer [Phase 2]
Phase 2 trial evaluating a regimen of carboplatin, etoposide, cyclophosphamide, and autologous bone marrow transplant in relapsed or refract…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial update investigating standard of care therapy with involved field radiation therapy for selective recurrent ovarian c…
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) [Phase 3]
Phase 3 trial (ARIEL3) evaluating rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cance…